当前位置: 首页 >> 检索结果
共有 8544 条符合本次的查询结果, 用时 2.1233332 秒

581. Trends in Injecting Methamphetamine and Opioids Among People Who Inject Drugs in the US.

作者: Angela D'Adamo.;Becky L Genberg.;Noa Krawczyk.;Jacqueline E Rudolph.;Shruti H Mehta.;Aaron A R Tobian.;Eshan U Patel.
来源: JAMA. 2026年335卷1期88-90页

582. Audio Highlights: October 31, 2025.

来源: JAMA. 2025年334卷20期e2418997页

583. As the 2026 Election Takes Shape, Health Care Is Becoming an Economic Issue for US Voters.

作者: Drew Altman.;Ashley Kirzinger.;Mollyann Brodie.
来源: JAMA. 2026年335卷5期393-394页

584. The One Big Beautiful Bill Act-Making Medicaid and the Exchanges Sustainable.

作者: Anup Malani.
来源: JAMA. 2026年335卷5期399-400页

585. Increasing Postpartum Use of GLP-1 Receptor Agonists.

作者: Mette Bliddal.;Gabra Nohmie.;Per Damkier.;Anton Pottegård.
来源: JAMA. 2025年334卷24期2227-2229页

586. Informing Patients About Use of AI Tools.

作者: Alison Weightman.;Philip Clayton.;Simon Coghlan.
来源: JAMA. 2026年335卷1期90-91页

587. Guiding Obstetric Care and Treatment Decisions for Women With Prior GLP-1 Receptor Agonist Use.

作者: Carolyn E Cesta.;Jennifer A Hutcheon.;Kari Johansson.
来源: JAMA. 2025年334卷24期2168-2170页

588. Informing Patients About Use of AI Tools-Reply.

作者: Michelle M Mello.;Danton Char.;Sonnet H Xu.
来源: JAMA. 2026年335卷1期91-92页

589. Continuous Glucose Monitoring.

作者: Richard M Bergenstal.;Thomas W Martens.;Roy W Beck.
来源: JAMA. 2025年334卷24期2220-2222页

590. Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.

作者: Jacqueline Maya.;Deepti Pant.;Yiran Fu.;Kaitlyn James.;Carolina Batlle.;Sarah Hsu.;Diana C Soria-Contreras.;Lydia L Shook.;Christopher Mow.;Marie-France Hivert.;Tanayott Thaweethai.;Camille E Powe.
来源: JAMA. 2025年334卷24期2186-2196页
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are contraindicated in pregnancy. Discontinuation of GLP-1RAs proximal to pregnancy could affect gestational weight gain and pregnancy outcomes.

591. Heavy Drinking May Lead to Earlier, More Severe Stroke.

作者: Shravya Pant.
来源: JAMA. 2025年334卷24期2155页

592. US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance.

作者: Kate Schweitzer.
来源: JAMA. 2025年334卷24期2149-2151页

593. Habit-Based Lifestyle Programs Linked to Metabolic Syndrome Remission.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷24期2156页

594. SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More-Highlights From Kidney Week.

作者: Jennifer Abbasi.
来源: JAMA. 2025年334卷24期2152-2154页

595. Most Young Adults With High LDL Miss Recommended Statin Treatment.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷24期2155页

596. Concerningly Low Self-Awareness of Chronic Kidney Disease.

作者: Shravya Pant.
来源: JAMA. 2025年334卷24期2155页

597. Resistance Training Improves Long COVID Outcomes.

作者: Shravya Pant.
来源: JAMA. 2025年334卷24期2156页

598. Midlife Heart Problems Associated With Heightened Dementia Risk.

作者: Shravya Pant.
来源: JAMA. 2025年334卷24期2155页

599. Prescription Stimulant Use Among US Adolescents.

作者: Yuchang Wang.;Xinle Xie.;Qingyun Lv.
来源: JAMA. 2025年334卷24期2230-2231页
共有 8544 条符合本次的查询结果, 用时 2.1233332 秒